NCT01969435View on ClinicalTrials.gov

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 19, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

May 31, 2017

Conditions

Hodgkin DiseaseLymphoma, Non-Hodgkin

Interventions

DRUG

Carmustine

DRUG

Etoposide phosphate

DRUG

Cytarabine

DRUG

Melphalan HCl (propylene glycol-free)

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT01969435 - Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma | Biotech Hunter | Biotech Hunter